ENVALITH
ユニ・チャーム株式会社 logo

UNICHARM CORPORATION

8113Prime MarketChemicals

ユニ・チャーム株式会社 logo
UNICHARM CORPORATION8113

Personal Care

Uni-Charm's core segment encompassing Wellness, Feminine, and Baby Care

PeriodCurrentPreviousChange
Net sales (Q1 FY2026, ending December 2026)¥190,996 million¥186,847 million (Q1 FY2025, ending December 2025)
Core operating profit (segment profit) (Q1 FY2026, ending December 2026)¥24,200 million¥21,823 million (Q1 FY2025, ending December 2025)
Core operating profit margin (Q1 FY2026, ending December 2026)12.7%11.7% (Q1 FY2025, ending December 2025)
Net sales year-on-year quarterly change+2.2%
Core operating profit year-on-year quarterly change+10.9%
Net sales (full year FY2025, ending December 2025; reference)¥774,428 million
Core operating profit (full year FY2025, ending December 2025; reference)¥83,197 million

Business Details

Composed of three categories: Wellness Care (adult incontinence care, masks), Feminine Care (sanitary products), and Baby Care (disposable diapers). While securing stable demand as daily necessities domestically, the segment has expanded into numerous overseas markets including Southeast Asia, China, the Middle East, and India. Of the consolidated net sales of ¥234,185 million for Q1 FY2026 (ending December 2026), this core segment accounted for ¥190,996 million (approximately 81.5%).

Recent Overview

Both net sales and core operating profit exceeded the same quarter of the prior year, with improved profitability

In the Personal Care segment for Q1 FY2026 (ending December 2026) (January to March 2026), net sales reached ¥190,996 million (up 2.2% year on year), and core operating profit reached ¥24,200 million (up 10.9% year on year). The core operating profit margin improved to 12.7% from 11.7% in the same quarter of the prior year. Domestically, market share was maintained steadily through stable demand as daily necessities and a broad product lineup. In China, despite the impact of upfront investment in emerging e-commerce platforms and intensifying competition, profitability improved, and business performance is beginning to show signs of recovery from the bottom. In India, both baby care and feminine care achieved high growth. Meanwhile, in Southeast Asia, the trend toward down-trading due to worsening economic sentiment continued.

Key Products

product
Wellness Care-related Products

Domestically, the segment maintains the No.1 market share centered on the 'Lifree' brand, offering an extensive lineup including pants-type and pad-type products. It also provides services such as the AI chatbot 'Charm-san' and adult diaper counseling. Overseas, the company is promoting the spread of the Japanese-style care model in Southeast Asian markets such as Thailand, Indonesia, and Vietnam. In China, the company is expanding its lineup of mild incontinence products and focusing on expanding awareness through SNS. In the mask category, the company offers both the 'Chokaiteki' and 'Chorittai' brands.

product
Feminine Care-related Products

Domestically, the segment continues to hold the No.1 market share with the 'Sofy' brand. The company is also strengthening digital touchpoints through the menstrual and health management app 'Sofy Be.' Overseas, high-value-added products such as cooling-type napkins, panty-type napkins, and activated-charcoal-infused napkins are being rolled out in Southeast Asia. In India, the company expanded the number of retail outlets carrying its products through the introduction of individually wrapped and flat-type products, achieving high sales growth. In China, sales during the Women's Day shopping season were achieved as planned.

product
Baby Care-related Products

Domestically, the segment continues to hold the No.1 market share with its two brands, 'Moony' and 'Mamy Poko,' achieving improved profitability. The company is also promoting environmental initiatives such as the 'Te-bura Toen' (hands-free daycare drop-off) service in collaboration with BABY JOB, and the use of recycled pulp. Overseas, in India, market share has remained at record-high levels due to expanded sales areas and continued awareness activities. In Indonesia, the company is addressing price competition through a two-brand strategy and the use of OEM supply. In Saudi Arabia, domestic market share reached a record high.

Growth Drivers

  • Sales growth from expanding demand related to aging in domestic Wellness Care and the rollout of high-value-added products (expansion of mild-to-moderate incontinence product lineup)
  • High sales growth from expanded penetration of baby care and feminine care in India (record-high market share, expanded number of retail outlets)
  • Sales growth and market share expansion from aggressive marketing investment in the Middle East (Saudi Arabia, etc.) (record-high domestic market share in Saudi Arabia)
  • Improved profitability and a recovery trend in the China market, including strategic upfront investment in emerging e-commerce platforms
  • Maximization of lifetime value through digital services in the femtech domain (Sofy Be) and AI chatbot (Charm-san)
  • Environmental consideration and differentiation through the use of recycled pulp from used diapers and the development of recycling models in collaboration with local governments

Risks

  • Continued risk of reputational damage related to sanitary products and baby care in the Chinese market (occurred in November 2024, and March and October 2025)
  • Down-trading and intensifying price competition in Southeast Asia (Indonesia, Thailand, Vietnam) due to declining birth rates and economic slowdown
  • Intensifying competition in Indonesia due to strengthened sales capabilities and price offensives by local companies, and risk of deteriorating distributor creditworthiness
  • Risk of logistics network disruption and export stagnation due to heightened tensions in the Middle East (impact on exports to countries neighboring Saudi Arabia)
  • Foreign exchange risk (impact on earnings from yen appreciation and local currency depreciation against the backdrop of U.S. monetary policy trends)
  • Risk of tax reform such as GST changes in India
  • Risk of impairment losses at subsidiaries in Malaysia, Indonesia, and China

Last updated: March 23, 2026